Search for: "In Re Omeprazole Patent Litigation"
Results 21 - 40
of 45
Sort by Relevance
|
Sort by Date
29 Aug 2008, 1:25 pm
: (IP finance), Facebook removes international access to Scrabulous, except from India: (Ars Technica), (Techdirt), Reverse engineering can resolve conflict between standardisation and competition: (Techdirt), Benefits of piracy aren’t always in the expected places: (Techdirt) Events 1-3 September: Federation of Indian Chambers of Commerce and Industry, Department of Industrial Property and Promotion, and WIPO conference on ‘Development and IP: Building synergies… [read post]
27 Aug 2008, 10:28 pm
The Federal Circuit affirmed the district court's finding on these issues, ending a decade long series of litigation over the popular heartburn medication.More on In re Omeprazole Patent Litig. after the jump. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to… [read post]
21 Aug 2008, 4:57 am
., and Torpharm Inc. on the one hand and Impax Laboratories on the other, were found to infringe the patents in suit, and... [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris:… [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous… [read post]
12 Jun 2008, 9:35 pm
In re Omeprazole Patent Litigation (07-1476, -1477, -1478). [read post]
12 Jun 2008, 4:45 am
Patent Nos. 4,786,505 and 4,853,230, which relate to oral pharmaceutical preparations for omeprazole. [read post]
12 Jun 2008, 3:22 am
In re Omeprazole Patent Litigation, Nos. 2007-1476, -1477, -1478 (Fed. [read post]
10 Jun 2008, 4:20 pm
IN RE OMEPRAZOLE PATENT LITIGATION (Fed. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes:… [read post]
7 Mar 2008, 2:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO upholds one of Wisconsin Alumni Research Foundation (WARF’s) human stem cell patents (decisions are pending on two other patents): (IPKat), (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (Patent Baristas), (IPBiz), English High Court rules Qualcomm’s patents invalid in battle… [read post]
3 Mar 2008, 9:27 pm
In re Omeprazole Patent Litigation (S.D.N.Y. 2007);6. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
28 Dec 2007, 1:00 am
: (Intellectual Property Directions),The young do not see copyright as a right: (Against Monopoly),Patent Troll concludes ‘patent litigation is out of control': (Against Monopoly),Are university researchers at risk for patent infringement? [read post]
2 Jul 2007, 2:51 pm
Apotex Prilosec: In re Omeprazole Patent Litigation Seroquel: AstraZeneca v. [read post]
4 Jun 2007, 8:16 pm
In re Omeprazole Patent Litigation, No. [read post]
7 May 2007, 3:39 am
All opinions are precedential unless otherwise indicated.In re Omeprazole Patent Litigation (04/23/2007): appeal of two phases of a four-phase patent infringement trial of literal infringement of several claims of the patent at issue, additional judgments regarding enforceability of the patent, and the determination by the district court that the asserted claims of the patent at issue were anticipated or obvious (affirmed);… [read post]
25 Apr 2007, 9:09 pm
Noonan -- The end of the consolidated omeprazole litigation may have been reached this week, when the Federal Circuit ruled on AstraZeneca's appeal over the validity of U.S. [read post]
